PRE-APPROVAL INSPECTION ISSUES DELAY BIMEKIZUMAB APPROVAL FOR SEVERE PLAQUE PSORIASIS – May 13, 2022.
Human Ventricular Progenitor Cells Promote the Formation of New Heart Tissue After MI – May 13, 2022
GUT MICROBIOME COMPOSITION PREDICTIVE OF PATIENT RESPONSE TO STATINS – May 12, 2022
National Lockdown in North Korea as ‘First’ Covid Case Reported – May 12, 2022
tiragolumab + Tecentriq Fails to meet Endpoints in Phase II trial of NSCLC – May 11, 2022
PFIZER TO ACQUIRE BIOHAVEN PHARMACEUTICALS FOR $11.6 BLN – MAY 10, 2022
YOUNGER CANCER PATIENTS ARE A HIGH-RISK FOR POOR OUTCOMES FROM COVID-19 INFECTION – MAY 9, 2022
HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED CVD RISK – MAY 9, 2022
GENDER SPECIFIC RISK FACTORS MAY PREDICT HEART ATTACKS IN YOUNG ADULTS – May 6, 2022
Omicron risks of hospitalization and mortality almost identical to other Variants – May 5, 2022
FDA Grants Imfinzi plus chemotherapy Priority Review for locally advanced or metastatic biliary tract cancer – May 4, 2022
PROCURE Study: The Importance of gene expression profile testing in guiding treatment decisions for early-stage breast cancer – May 4, 2022
FDA APPROVES CUVRIOR™ FOR PATIENTS WITH STABLE WILSON’S DISEASE WHO ARE DE-COPPERED AND TOLERANT TO PENICILLAMINE– MAY 3, 2022
INSULIN NASAL SPRAY MAY IMPROVE BRAIN HEALTH, & PREVENT ALZHEIMER’S IN NON-DIABETICS – MAY 3, 2022
FDA DECLINES APPROVAL OF 2 CANCER MEDS TESTED IN CHINA – MAY 2, 2022
AMERICAN ACADEMY OF PEDIATRICS CALLS FOR ELIMINATION OF RACE-BASED MEDICINE – MAY 2, 2022
cdc rEPORTS: fIRST us Case of Human Avian Influenza A(H5) – aPRIL 29, 2022
CAMZYOS™ (MAVACAMTEN) APPROVED FOR SYMPTOMATIC CLASS II – III OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY – April 29, 2022
PFIZER RESTARTS PHASE 3 CIFFREO GENE THERAPY TRIAL – April 28, 2022
NEW MODEL PREDICTS PATIENTS WITH POOR LUNG CANCER OUTCOMES – APRIL 27, 2022 |
HUMAN CASE OF H3N8 BIRD FLU REPORTED IN HENAN CHINA – APRIL 27, 2022 |
POSITIVE PHASE 2 PEDIATRIC DATA FOR LYME DISEASE VACCINE CANDIDATE – APRIL, 26, 2022 |
NEKTAR CUTS 70% OF WORKFORCE – APRIL 26, 2022 |
Drug-resistant form of Aspergillus fumigatus (environmental mold) capable of infecting people – April 25, 2022
War in Ukraine Disrupts multiple sclerosis drug development – April 25, 2022
WHO: 1 Death and 169 Cases of Pediatric Hepatitis Reported in 12 Countries – April 24, 2022